News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Amundi has made a new investment of $847,000 in Diversified Healthcare Trust (DHC) by purchasing 127,594 shares, giving it a 0.05% stake in the company. Other institutional investors have also adjusted their holdings in DHC, which reported slightly missed quarterly earnings expectations and declared …
Diversified Healthcare Trust (DHC) has received a "Moderate Buy" consensus rating from six analysts, with an average 12-month price target of $9.83. Institutional ownership stands at approximately 75.98%, with significant increases from Bank of America and a new position from Bank of New York …
Dimensional Fund Advisors LP increased its stake in Diversified Healthcare Trust (DHC) by 6.1%, purchasing an additional 138,708 shares to now own 2.4 million shares, or 0.99% of the REIT. Institutional investors collectively own 75.98% of DHC, which currently holds a "Moderate Buy" consensus …
Diversified Healthcare Trust (NASDAQ: DHC) 6.25% SR NT 01/02/46 USD is scheduled to go ex-dividend on August 14th, 2026. The dividend payment will be 0.39063 USD per share. This information is crucial for investors tracking dividend distributions for this security.
Diversified Healthcare Trust (DHC) is in focus after its Q2 2026 earnings report, showing strong share price momentum and improved net loss figures. Despite this, the stock is considered 7.2% undervalued with a fair value of $9.88 per share, based on expected cash flow …
Diversified Healthcare Trust (DHC) reported lower-than-expected occupancy and revenue in Q2 2026, which CEO Chris Bilotto attributed to "transition noise" from switching operators for 116 communities. Despite this, the company saw sequential occupancy gains and increased NOI margins, reaffirming its SHOP NOI guidance for …
Diversified Healthcare Trust (DHC) reported strong Q2 results, with consolidated NOI up 20.4% year over year, driven by a significant jump in senior housing operating portfolio (SHOP) NOI and improved occupancy and rates. The company reaffirmed its 2026 guidance for adjusted EBITDARE and normalized …
Diversified Healthcare Trust (DHC) reported a Q2 2026 loss of $0.16 per share on revenue of $365.39 million, missing analyst expectations. Despite the miss, the company reaffirmed its full-year guidance, driven by strong operating trends, particularly in its senior housing operating properties (SHOP) segment, …
Diversified Healthcare Trust (DHC) reported narrower losses in Q2 2026, with a net loss of US$37.42 million despite softer revenue. While this shows progress in reducing financial damage, the company still faces ongoing revenue pressure and high leverage, making refinancing risk a key concern …
Diversified Healthcare Trust (DHC) reported second-quarter Funds From Operations (FFO) of $0.16 per share, surpassing the Zacks Consensus Estimate of $0.14 per share and significantly higher than $0.08 per share a year ago. Despite missing revenue estimates, the company's FFO surprise was +14.29%, and …
Diversified Healthcare Trust (DHC) reported its second-quarter revenue as $365.4 million, falling short of FactSet's estimate of $370.8 million. This earnings flash provides key financial data for the quarter, highlighting a slight miss on revenue expectations. The article also lists recent news and analyst …
Diversified Healthcare Trust (DHC) announced its financial results for the second quarter ended June 30, 2026, and provided updated full-year 2026 financial guidance. The company will host a conference call on August 4, 2026, to discuss these results. DHC is a real estate investment …
Diversified Healthcare Trust (DHC) reported strong Q2 2026 financial results, with Normalized FFO increasing by 109.4% year-over-year to $38.9 million. The company saw significant improvements in its senior housing operating portfolio, with same property SHOP NOI growing 37.2%, and its Medical Office and Life …
Diversified Healthcare Trust is set to report its Q2 results, with analysts expecting a loss of $0.14 per share on $367.6 million in revenue, an improvement from the previous quarter. Investors will be looking to see if the company can deliver on its raised …
RBF Capital LLC reduced its stake in Diversified Healthcare Trust (DHC) by 15.5% in the first quarter, selling 177,475 shares and retaining 966,829 shares valued at $6.42 million. Diversified Healthcare Trust's stock has an average rating of "Moderate Buy" from analysts, with an average …
This article analyzes Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (NASDAQ: DHCNL), highlighting a weak near-term sentiment despite potential long-term strength. It presents AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal …
Diversified Healthcare Trust (DHC) is scheduled to announce its Q2 2026 earnings after market close on Monday, August 3rd. Analysts are projecting a loss of $0.1467 per share on revenue of $370.7550 million. The company's prior quarter missed expectations with an $0.18 per share …
Diversified Healthcare Trust (NASDAQ: DHC) generated $1.54 billion USD in revenue last year. The majority of this revenue, $1.31 billion USD, came from its top-performing "SHOP" segment, an increase from $1.24 billion the prior year. The United States was the primary geographic contributor, accounting …
HSBC Holdings PLC significantly increased its stake in Diversified Healthcare Trust (NASDAQ:DHC) by 579.4% in the first quarter, now holding 381,632 shares valued at approximately $2.53 million. Institutional investors collectively own 75.98% of DHC shares, with several firms initiating or expanding positions. Despite a …
This article provides a coupon profile for the Diversified Healthcare Trust DHC4597741 bond, detailing its coupon rate and upcoming payment schedule. The bond has a current coupon rate of 4.75%, and the next interest payment is scheduled for August 17, 2026. The information presented …
Militia Capital Management LLC has acquired 214,139 shares of Diversified Healthcare Trust (NASDAQ:DHC) valued at approximately $1.42 million. This move contributes to the substantial institutional ownership of DHC, which stands at 75.98%. Despite a recent earnings miss and modest dividend announcement, analysts maintain a …
This article provides an overview of the DHCNI bond (Diversified Healthcare Trust - 5.625% Senior Notes due 2042) on TradingView. It offers a bond risk profile including credit risk assessment, inflation protection, and issuer rating to help evaluate reliability. Users can also access analyst …
This article provides key metrics for the DHCNI bond, issued by Diversified Healthcare Trust. The bond is a 5.625% Senior Note due in 2042, with a face value of $25.00 and a 5.63% coupon. Diversified Healthcare Trust is a real estate investment trust focused …
This article provides a liquidity mapping analysis for Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (NASDAQ: DHCNL), highlighting neutral near and mid-term readings but a potential long-term positive bias. It identifies a strong resistance test, suggesting a possible short setup with a favorable …
Diversified Healthcare Trust (DHC) is scheduled to go ex-dividend on July 20th, 2026. The company will be distributing a dividend of $0.01 per share to its shareholders. Investors wishing to receive this dividend must own shares before the ex-dividend date.
This article provides a detailed profile of the DHC5125451 bond issued by Diversified Healthcare Trust. Key metrics such as coupon rate, issue and maturity dates, outstanding amount, and face value are presented. It also describes Diversified Healthcare Trust as a real estate investment trust …
Diversified Healthcare Trust (NASDAQ:DHC) has received a consensus "Moderate Buy" rating from six brokerages, with an average 12-month price target of $9.83. Despite recent mixed analyst actions including upgrades and downgrades, 75.98% of the stock is owned by institutional investors. The company recently reported …
Search by ticker symbol or company name and select a result to open its chart.